Carna Biosciences Inc.

Carna Biosciences Inc. is a biotechnology company specializing in research and development of innovative drug discovery technologies. The primary focus of Carna Biosciences is the kinase inhibitor market, where it capitalizes on its proprietary kinase screening platform. This platform is designed to facilitate the identification and optimization of potential drug candidates for a range of therapeutic areas. Carna's extensive kinase library serves as a valuable resource for pharmaceutical companies engaged in developing targeted treatments for diseases such as cancer, inflammation, and infectious conditions. By offering comprehensive drug discovery services and partnering with leading global biotech and pharma firms, Carna Biosciences plays a crucial role in advancing medical research and expanding therapeutic options. Headquartered in Japan, the company is strategically positioned to influence the direction of new drug development, contributing significantly to the innovation pipeline within the biotechnology sector.